Read More Pharma Industry News Phase 2 trial of RLS-0071 : ReAlta’s innovative approach to treating rare newborn disease ReAlta Life Sciences, Inc., a clinical mid-stage biotech company focusing on rare life-threatening diseases, has announced the commencement… byPallavi MadhirajuAugust 1, 2023